Incorporation of a Novel CD16-Specific Single-Domain Antibody into Multispecific Natural Killer Cell Engagers With Potent ADCC
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incorporation of a Novel CD16-Specific Single-Domain Antibody into Multispecific Natural Killer Cell Engagers With Potent ADCC
Authors
Keywords
-
Journal
MOLECULAR PHARMACEUTICS
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2021-05-18
DOI
10.1021/acs.molpharmaceut.1c00208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunogenicity and humanization of single‐domain antibodies
- (2021) Martin A. Rossotti et al. FEBS Journal
- Serum albumin‐binding V H Hs with variable pH sensitivities enable tailored half‐life extension of biologics
- (2020) Henk van Faassen et al. FASEB JOURNAL
- Nanobody-CD16 catch bond reveals NK cell mechanosensitivity
- (2019) Cristina Gonzalez et al. BIOPHYSICAL JOURNAL
- Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
- (2019) Laurent Gauthier et al. CELL
- Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
- (2019) Kristina Ellwanger et al. mAbs
- Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies
- (2019) Yining Zhao et al. CANCER BIOLOGY & THERAPY
- Killers 2.0: NK cell therapies at the forefront of cancer control
- (2019) Jonathan J. Hodgins et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine
- (2019) Sietse Q. Nagelkerke et al. Frontiers in Immunology
- Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model
- (2018) Danielle Mandikian et al. MOLECULAR CANCER THERAPEUTICS
- Camelid single-domain antibodies raised by DNA immunization are potent inhibitors of EGFR signaling
- (2018) Martin A. Rossotti et al. BIOCHEMICAL JOURNAL
- A single amino acid distorts the Fc γ receptor IIIb/CD16b structure upon binding immunoglobulin G1 and reduces affinity relative to CD16a
- (2018) Jacob T. Roberts et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A disulfide-stabilized human V L single-domain antibody library is a source of soluble and highly thermostable binders
- (2017) Kevin A. Henry et al. MOLECULAR IMMUNOLOGY
- Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human VH/VL Single-Domain Antibodies from In Vitro Display Libraries
- (2017) Kevin A. Henry et al. Frontiers in Immunology
- Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity
- (2016) Jing Li et al. CANCER BIOLOGY & THERAPY
- A novel bispecific antibody, BiSS, with potent anti-cancer activities
- (2016) Bin Dong et al. CANCER BIOLOGY & THERAPY
- Identification of high-affinity anti-CD16A allotype-independent human antibody domains
- (2016) Wei Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor
- (2016) Ganesh P. Subedi et al. mAbs
- Isolation of TGF-β-neutralizing single-domain antibodies of predetermined epitope specificity using next-generation DNA sequencing
- (2016) Kevin A. Henry et al. PROTEIN ENGINEERING DESIGN & SELECTION
- A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies
- (2016) Kevin A. Henry et al. PLoS One
- A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
- (2015) A. Rothe et al. BLOOD
- Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies
- (2014) Zhijie Jey Cheng et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+tumor cells
- (2014) Uwe Reusch et al. mAbs
- Stability engineering of scFvs for the development of bispecific and multivalent antibodies
- (2010) Brian R. Miller et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen
- (2009) Ghislaine Behar et al. FEBS Journal
- General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
- (2008) Cécile Vincke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search